Methylprednisolone Taper After Total Knee Replacement

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

July 23, 2025

Study Completion Date

July 23, 2025

Conditions
Knee Arthritis
Interventions
DRUG

Methylprednisolone

"Patients will receive a single intraoperative dose of 10 mg intravenous dexamethasone followed with a 6-day oral methylprednisolone taper course.~Patients will also receive a standardized multimodal postoperative pain management regimen which includes nonsteroidal anti-inflammatory medication (e.g., NSAIDs) and opioid pain medications, both in the hospital and at home as part of standard care."

OTHER

Standard of Care

"Patients will receive a single intraoperative dose of 10 mg intravenous dexamethasone (control group, IV dexamethasone is standard of care).~Patients will also receive a standardized multimodal postoperative pain management regimen which includes nonsteroidal anti-inflammatory medication (e.g., NSAIDs) and opioid pain medications, both in the hospital and at home as part of standard care."

Trial Locations (2)

30084

Emory University Orthopaedics & Spine Hospital, Tucker

30329

Emory Musculoskeletal Institute, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT05859269 - Methylprednisolone Taper After Total Knee Replacement | Biotech Hunter | Biotech Hunter